A. Larocque

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Pascal Tétreault, Nicolas Beaudet, Philippe Sarret, 2014, The Journal of clinical investigation.

The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers

R. Béliveau, B. Annabi, M. Demeule, 2022, Cancers.

Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain

L. Gendron, Gaoqiang Yang, P. Sarret, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Abstract 6362: TH1901, a novel curcumin-peptide conjugate for the treatment of Sortilin-positive (SORT1+) cancer

R. Béliveau, B. Annabi, M. Demeule, 2020 .

New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells

R. Béliveau, B. Annabi, M. Demeule, 2021, Frontiers in Oncology.

TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer

R. Béliveau, B. Annabi, M. Demeule, 2021, Cancer science.

Structural comparison of alanine-substituted analogues of the calcitonin gene-related peptide 8-37. Importance of the C-terminal segment for antagonistic activity.

A. Fournier, S. St.-Pierre, Y. Boulanger, 2009, International journal of peptide and protein research.

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

J. Lachowicz, R. Leduc, R. Béliveau, 2014, The Journal of clinical investigation.

NMR and molecular modeling characterization of HIV-1 protease inhibitors: Difunctional enols of N-protected phenylalanine

Y. Boulanger, A. Larocque, G. Sauvé, 1997 .